CD274 and melanoma: In contrast, the expression of CD73 on EVs, which produces adenosine and contributes to T-cell suppression, was found to increase early on-treatment among melanoma patients who failed to respond to ICI [291], suggesting the potential clinical relevance of assessing molecules beyond PD-L1 during treatment with ICI.